SEC Form 4 · accession 0000899243-19-004574
LogicBio Therapeutics, Inc. · LOGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Huttner
Officer — SVP, Head of Clinical Dev.
Period of report
Feb 20, 2019
Accepted (ET)
Feb 22, 2019 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001664106
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.06 | Feb 20, 2019 | A | 50,818 | A | — | Feb 19, 2029 | Common Stock | 50,818 | 50,818 | D |
Explanation of responses
- F1The option will vest as to 25% of the shares on the first anniversary of the grant date and in equal monthly installments over the next three years.